Skip Navigation Links
 Home 
 Registration 
 Pre Registered 
  
 Personal page 
 Archive 
Scroll up
Scroll down
-
-
Scroll up
Scroll down
       XXII Annual Congress of the Iranian Society of Ophthalmology        بـیــست و دومــیــن کنــگــره سـالیـانه انـجـمـن چـشـم پـزشـکی ایـــران
Skip Navigation Links
        صفحه اصلی
        ساختار همایش
        مکان برگزاری
        ثبت نام
        ثبت نام شدگان
         مقالات
        مقالات پذیرفته شده
        ارسال پوستر
        برنامه همایش
        تماس با ما
        صفحه شخصی
        جستجوی سخنران
        آرشیو سمينار سالهای گذشته
 
مقاله Abstract


Title: Intravitreal propranolo for the treatment of choroidal neovascularization
Author(s): Hamid Ahmadieh, Ramin Nourinia, Mozhghan Rezaei Kanavani, Amir Kahrkabodi
Presentation Type: Oral
Subject: Retina and Retinal Cell Biology
Others:
Presenting Author:
Name: Ramin Nourinia
Affiliation :(optional) Ophthalmic Research center, shahid beheshti university of medical sciences
E mail: ramin.retin@gmail.com
Phone: 04413365316
Mobile: 09128249332
Purpose:

Determination effect of intravitreal propranolol in the treatment of choroidal neovascularization (CNV).

Methods:

Forty two C57BL/6J mice were selected for this study.For the assessment of the efficacy of intravitreal propranolol on CNV, bruch’s membrane of mice was ruptured by laser burns for inducing CNV. Then mice were randomly received safe dose (0.3µg) of intravitreal propranolol or intravitreal normal saline. Neovascularization was measured on choroidal-scleral flat mounts using intercellular adhesion molecule 2 immunofluorescence staining.

Results:

Mice eyes treated with intravitreal injection of propranolol showed significantly smaller neovascular choroidal outgrowths compared to the control. An approximately 4.8-fold decrease in the average CNV area in each eye was observed in the propranolol-treated (mean [SE], 17945 [25971] µm2; n=21 eyes) compared with the control (mean [SE], 86821 [49274] µm2; n=17 eyes), which was statistically significant (p<0.001.

Conclusion:

Intravitreal propranolol had an inhibitory effect on the growth of laser-induced CNV in the murine eyes. Further studies are required to confirm whether intravitreal propranolol can be a proper treatment for ocular neovascular disorders.

Attachment:





Last News

  - بـیــست و دومــیــن کنــگــره سـالیـانه انـجـمـن چـشـم پـزشـکی ایـــران